3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
Specimen Handling
6
Paclitaxel
6
Magnetic Resonance Spectroscopy
5
Nivolumab
4
Carboplatin
4
Biopsy
4
pembrolizumab
2
olaparib
2
ceralasertib
2
Taxes
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
ribociclib
1
rebastinib
1
pelcitoclax
1
pamiparib
1
durvalumab
1
cobimetinib
1
cediranib
1
cabozantinib
1
belinostat
1
atezolizumab
1
X-Rays
1
Tissue Banks
1
TIC10 compound
1
Ipilimumab
1
Immunoglobulin G
1
Ifosfamide
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
X-Rays
×
Gynecologic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled